Theophila GmbH arranges medical treatments and provides medical advisory services for stem cell and exosome therapies, including via the Medical Cells Network platform. The company supports personalised therapy selection, coordinates clinic placements and offers patient consultations based on medical protocols.
Independent medical advisory for stem cell and exosome therapies, with personalised consultation, therapy selection, clinic coordination, preparation and remote follow-up.
Coordination of stem cell and exosome therapies
Coordination of treatment programs in selected clinics in Germany, Switzerland and Georgia, with medical assessment and support before, during and after treatment.
Personalised medical consultation
Personalised medical consultation based on medical history, diagnosis and current treatment, with an assessment of the suitability of stem cell or exosome therapy.
Treatment recommendation and program selection
Individual selection of therapy, cell type and treatment program according to indication, disease stage and medical assessment.
Exosome Therapy
Exosome therapy as an accompanied treatment option for various indications, including neurological conditions and anti-aging/rejuvenation.
Stem cell therapies for neurological diseases
Stem cell therapies for Parkinson's, multiple sclerosis, Alzheimer's, ALS, autism and cerebral palsy, tailored to diagnosis and disease stage.
Stem cell therapies for diabetes
Stem cell-based treatment advisory for diabetes, with selection of a suitable protocol based on the medical situation.
Anti-Ageing and Rejuvenation
Advisory on rejuvenation and healthy ageing with stem cell and exosome therapies.
Partner program for referrers
Partner and referral collaboration for medical agencies, doctors, longevity centres, concierge medicine and patient communities.
Comparisons
Theophila GmbH in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Theophila GmbH by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Theophila GmbH has claimed this profile, we'll publish editorial articles and case studies here together.